Minimum Viable Product (MVP) for medication verification

project efc35b7725713a92
Normalized: minimum viable product mvp for medication verification
moreland_contracts
Entity Properties (gold project table)
project_id
efc35b7725713a92
name
Minimum Viable Product (MVP) for medication verification
client_id
canonical_metadata
created_at
2026-05-02 02:29:59.020102+00:00
updated_at
2026-05-02 02:29:59.020102+00:00
status
billable
recurring
squad
qa_partner
project_manager
lead_dev
description
state
team_name
closedate
dealstage
deal_amount
contract_type
contract_hourly_rate
contract_estimated_hours
contract_total_fee
52%
Separation Confidence How distinct this entity is from others. Higher means no close matches existed when it was created. Lower means a near-match was rejected just below the 80% threshold — worth reviewing.
Moderate — a somewhat similar entity exists
100%
Avg Match Confidence The average confidence score across all active source mappings. Shows overall quality of linkage between source records and this canonical entity.
Strong source linkage

Source Mappings (3)

Source Source ID Display Name Confidence Method Status Actions
moreland_contracts 013b9a2fc6ff831ce4541fe4dddc2ffe Minimum Viable Product (MVP) for medication verification 1.00 fuzzy+embedding Active
Source Record bronze_moreland_contracts_ma_project_contracts
file_hash
013b9a2fc6ff831ce4541fe4dddc2ffe
file_name
PharmaVy__-_Moreland_Arrangement_Letter.docx.pdf
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/Shared%20Documents/Internal%20-%20Business%20Development/XXX%20ARCHIVE/Pharmavy/PharmaVy__-_Moreland_Arrangement_Letter.docx.pdf
company
PharmaVy
project_name
Minimum Viable Product (MVP) for medication verification
contact_person
Brent Boyko
contract_type
fixed_fee
hourly_rate
estimated_hours
total_fee_estimate
25000.0
brief_project_description
Design, develop, and deliver a Minimum Viable Product (MVP) for medication verification, validation and accountability for EMS and Hospital Integration.
start_date
2025-04-21
extracted_at
2026-06-30T02:19:27.363419+00:00
raw_text_preview
1960 CASE PARKWAY S TWINSBURG , OHIO 44087 April 10, 202 5 Dear Brent : MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the "Services") to assist PharmaVy . (“PharmaVy ”) Project Approach PharmaVy will prioritize work and communicate to the Moreland resources using normal communication channels (e.g., email, phone , meetings) . The Moreland team will work with PharmaVy to coordinate the implementation of tested and approved modifications to the software. Responsibilities The following table outlines the key responsibilities for PharmaVy and Moreland . Organization Key Responsibilities PharmaVy  Appoint a PharmaVy project leader to direct team activities and assist with project execution .  Prioritize and communicate desired fixes and enhancements to be completed by Moreland  Review and approve completed modifications  Assist in the creation of project deliverables MorelandConnect  Work with PharmaVy to manage the project plan and creation of deliverables  Participa te in the activities described in the “Project Activ ities, Scope, and Approach” section above  Coordinate / Manage Project activities Moreland will perform the Services at MorelandConnect and PharmaVy office location s. Docusign Envelope ID: 95FB43DA-0CAB-415D-92EC-92A54188557F 1960 CASE PARKWAY S TWINSBURG , OHIO 44087 1. Objective The goal of this engagement is to efficiently design, develop, and deliver a Minimum Viable Product (MVP) for medication verification, validation and accountability for EMS and Hospital Integration . Will include RFID Reader and EPCR integration. Goal is to enhances medication verification and accountability within EMS and hospital systems through RFID technology, enabling efficient scanning and integr ation with existing Electronic Patient Care Report systems. A critical aspect is the improvement of the
file_created_at
2025-05-12T17:41:17+00:00
file_modified_at
2025-05-12T17:39:05+00:00
created_by
Paul Franke
modified_by
Paul Franke
_dlt_meta
moreland_contracts 557e0d170fdbcaa984e71f238cf1281d Minimum Viable Product (MVP) for medication verification 1.00 exact Active
Source Record bronze_moreland_contracts_ma_project_contracts
file_hash
557e0d170fdbcaa984e71f238cf1281d
file_name
PharmaVy - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7BF7286F0F-3AF5-4C16-8963-22B9C044AE80%7D&file=PharmaVy%20%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
PharmaVy
project_name
Design to MVP Sprint
contact_person
Brent
contract_type
fixed_fee
hourly_rate
estimated_hours
total_fee_estimate
25000.0
brief_project_description
Design, develop, and deliver a Minimum Viable Product (MVP) for medication verification, validation and accountability for EMS and Hospital Integration using RFID technology.
start_date
2025-04-10
extracted_at
2026-07-02T02:21:37.807611+00:00
raw_text_preview
April 10, 2025 Dear Brent: MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the "Services") to assist PharmaVy. (“PharmaVy”) Project Approach PharmaVy will prioritize work and communicate to the Moreland resources using normal communication channels (e.g., email, phone, meetings). The Moreland team will work with PharmaVy to coordinate the implementation of tested and approved modifications to the software. Responsibilities The following table outlines the key responsibilities for PharmaVy and Moreland. Moreland will perform the Services at MorelandConnect and PharmaVy office locations. 1. Objective The goal of this engagement is to efficiently design, develop, and deliver a Minimum Viable Product (MVP) for medication verification, validation and accountability for EMS and Hospital Integration. Will include RFID Reader and EPCR integration. Goal is to enhances medication verification and accountability within EMS and hospital systems through RFID technology, enabling efficient scanning and integration with existing Electronic Patient Care Report systems. A critical aspect is the improvement of the drug administration workflow, which currently relies on manual calculations for dosing, particularly in pediatric cases. The new system would automate dosage calculations based on scanned information, reducing errors and enhancing patient safety. 2. Scope of Work The engagement will consist of the following phased approach: Week 1 – Discovery Session 1: Kick-off, Mapping and Ideation (3 hours, In-Person with Signet) 1. Introductions and Sprint Overview Time: 30 minutes Implementation: Round table introductions Present sprint agenda PharmaVy focus and impact 2. Set Long-Term Goals and Sprint Questions Time: 30 minutes Implementation: Define project purpose Establish future vision Identify key sprint questions Frame goals around PharmaVy capabilities 3. Map Current State Time: 60 minut
file_created_at
2025-09-09T17:53:41+00:00
file_modified_at
2025-09-09T17:53:41+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
moreland_contracts 70230e9f4f1aa2d0b0856ced2625ab86 Minimum Viable Product (MVP) for medication verification 1.00 exact Active
Source Record bronze_moreland_contracts_ma_project_contracts
file_hash
70230e9f4f1aa2d0b0856ced2625ab86
file_name
Complete_with_Docusign_PharmaVy__-_Moreland_.pdf
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/Shared%20Documents/Internal%20-%20Business%20Development/XXX%20ARCHIVE/Pharmavy/Complete_with_Docusign_PharmaVy__-_Moreland_.pdf
company
PharmaVy
project_name
Minimum Viable Product (MVP) for medication verification
contact_person
Brent Boyko
contract_type
fixed_fee
hourly_rate
estimated_hours
total_fee_estimate
25000.0
brief_project_description
Design, develop, and deliver a Minimum Viable Product (MVP) for medication verification, validation and accountability for EMS and Hospital Integration.
start_date
2025-04-21
extracted_at
2026-07-02T02:21:35.588226+00:00
raw_text_preview
1960 CASE PARKWAY S TWINSBURG , OHIO 44087 April 10, 202 5 Dear Brent : MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the "Services") to assist PharmaVy . (“PharmaVy ”) Project Approach PharmaVy will prioritize work and communicate to the Moreland resources using normal communication channels (e.g., email, phone , meetings) . The Moreland team will work with PharmaVy to coordinate the implementation of tested and approved modifications to the software. Responsibilities The following table outlines the key responsibilities for PharmaVy and Moreland . Organization Key Responsibilities PharmaVy  Appoint a PharmaVy project leader to direct team activities and assist with project execution .  Prioritize and communicate desired fixes and enhancements to be completed by Moreland  Review and approve completed modifications  Assist in the creation of project deliverables MorelandConnect  Work with PharmaVy to manage the project plan and creation of deliverables  Participa te in the activities described in the “Project Activ ities, Scope, and Approach” section above  Coordinate / Manage Project activities Moreland will perform the Services at MorelandConnect and PharmaVy office location s. Docusign Envelope ID: 95FB43DA-0CAB-415D-92EC-92A54188557F 1960 CASE PARKWAY S TWINSBURG , OHIO 44087 1. Objective The goal of this engagement is to efficiently design, develop, and deliver a Minimum Viable Product (MVP) for medication verification, validation and accountability for EMS and Hospital Integration . Will include RFID Reader and EPCR integration. Goal is to enhances medication verification and accountability within EMS and hospital systems through RFID technology, enabling efficient scanning and integr ation with existing Electronic Patient Care Report systems. A critical aspect is the improvement of the
file_created_at
2025-04-21T20:28:35+00:00
file_modified_at
2025-04-21T20:28:35+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta